The aim of the present study was to investigate the effect of pemetrexed-induced TS-inhibition on 18F-FLT uptake 4 hours after pemetrexed administration in patients with metastatic NSCLC. The gene discussed is TYMS; the disease is non-small cell lung carcinoma.